This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 16-18, 2025
Hynes Convention CenterBoston, MA

Victor Manuel Diaz Cortes
Research Director at OneChain Immunotherapeutics S.L.
Speaker

Profile

Dr. Víctor M. Díaz, PhD in Biochemistry, is the Research Director at OneChain Immunotherapeutics (OCI), specializing in CAR-T cell therapies for hematological malignancies. He has contributed to securing EMA and FDA orphan drug designations, clinical trial approvals, and multiple CAR patents. With extensive experience in academia and research, he leads a multidisciplinary team advancing autologous and allogeneic cell therapies for cancer treatment.

Agenda Sessions

  • Stromal-Free, GMP-Compatible Bioprocess for Generating Allogeneic CAR-γδ T Cells from Cord Blood CD34+ HSPC

    11:15am